Serum Institute Partners with Gates MRI to Make Experimental TB Vaccine

Gates MRI, Serum Institute sign deal to manufacture novel TB vaccine candidate

Currently in a Phase 3 clinical trial, M72/AS01E has the potential to become the first new TB vaccine introduced in more than a century.

Serum Institute to invest $ 100 million for TB vaccine, signs agreement with Gates MRI

The Gates Medical Research Institute and Serum Institute of India have signed an agreement to mass-produce the M72/AS01E tuberculosis vaccine candidate, potentially introducing the first new TB vaccine in over a century.

SII & Gates MRI ink pact to manufacture new TB vaccine candidate after successful Phase 3 trials

Serum Institute of India and Gates MRI to manufacture M72/AS01E TB vaccine candidate in Phase 3, aiming for scalable supply for high-burden countries.

Gates MRI, SII tie-up for manufacture TB vaccine candidate

SII was selected based on its record of producing WHO-prequalified vaccines, affordably and at scale, and meeting stringent global quality and regulatory standards, according to the statement.

Gates MRI, Serum Institute of India Sign Agreement to Manufacture Tuberculosis Vaccine Candidate

Get latest articles and stories on India at LatestLY. The Gates Medical Research Institute (Gates MRI) on Thursday signed an agreement with the Serum Institute of India Private Limited (SII) to manufacture a novel tuberculosis (TB) vaccine candidate, M72/AS01E. India News | Gates MRI, Serum Institute of India Sign Agreement to Manufacture Tuberculosis Vaccine Candidate.

Serum Institute partners with Gates MRI to make experimental TB vaccine

Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical trials. Gates Medical Research Institute will transfer manufacturing technology and know-how. The company plans to invest over one hundred million dollars for production. This new shot could prevent millions of cases and save lives.